Barbara Milczarek for The World of Pharmaceutical Industry Magazine!
In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.
In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.
We invite you to read the full article in polish.
The 2023 International Trademark Association (INTA) meeting is approaching very soon, and traditionally it cannot be Czytaj dalej
In the latest IP Stars 2020 ranking recognizing the best IP law firms in terms Czytaj dalej
A trademark cannot contain the symbol of cannabis. Such was the decision of the General Czytaj dalej
